(firstQuint)TAK-114 Single- and Multiple-Dose Phase 1 Study.

 This is a phase 1, randomized, double-blind, placebo-controlled, single and multiple oral dose study in healthy Caucasian and Japanese male participants.

 The study is composed of three parts, Single-dose Ascending Part, Food Effect Part and Multiple-dose Ascending Part.

 Single-dose Ascending Part and Multiple-dose Ascending Part are designed as a randomized, double-blind or open-label, placebo-controlled, sequential-cohort, ascending single or multiple oral dose study of TAK-114 or matched placebo.

 The Food Effect Part is designed as a randomized, open-label, 2-period crossover study of a single dose of TAK-114.

.

 TAK-114 Single- and Multiple-Dose Phase 1 Study@highlight

The purpose of this study is to evaluate the safety and tolerability of TAK-114 following single and multiple ascending oral doses in healthy Japanese male participants.

